Despite a lower P/S ratio than industry peers due to shrinki...
Despite a lower P/S ratio than industry peers due to shrinking revenue, this may decrease if the company doesn't remedy its growth. Conservatism in stock prices is expected barring significant changes. Even the recent share price surge didn't raise the P/S to the industry median.
HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE:002437) Held Back By Insufficient Growth Even After Shares Climb 30%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment